Ki67 targeted strategies for cancer therapy

被引：224
|
作者：
Yang, C. [1 ]
Zhang, J. [1 ]
Ding, M. [1 ,2 ]
Xu, K. [1 ,2 ]
Li, L. [1 ]
Mao, L. [1 ,2 ]
Zheng, J. [1 ]
机构：
[1] Xuzhou Med Univ, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R China
[2] Univ Med Coll, Affiliated Hosp, Dept Urinary Surg, Xuzhou 221000, Peoples R China
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2018年 / 20卷 / 05期
关键词：
Ki67; Gene therapy; Renal cancer; siRNA; Target therapy; Proliferation; PROLIFERATION-ASSOCIATED ANTIGEN; SELECTIVE ADENOVIRUS ONYX-015; SMALL-INTERFERING-RNA; PHASE-I TRIAL; ONCOLYTIC ADENOVIRUS; ANTISENSE OLIGONUCLEOTIDE; PROSTATE-CANCER; BREAST-CANCER; INTRAVENOUS-INFUSION; ANTITUMOR-ACTIVITY;
D O I：
10.1007/s12094-017-1774-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ki67 is a well-known proliferation marker for the evaluation of cell proliferation. Numerous studies have indicated that Ki67 index independently predicts cancer progression. Moreover, because Ki67 is highly expressed in malignant cells but almost could not be detected in normal cells, it has become a promising target for cancer therapy. In this review, we summarize recent advances in Ki67 targeted cancer therapy. In particular, we highlight recent development on the exploitation of Ki67 promoter to drive the expression of siRNAs or therapeutic genes in cancer cells specifically. The use of Ki67 as an attractive target opens a new avenue for cancer therapy.
引用
收藏
页码：570 / 575
页数：6
相关论文
共 50 条
  • [21] Correlation between Ki67 and Breast Cancer Prognosis
    Kontzoglou, Konstantinos
    Palla, Victoria
    Karaolanis, George
    Karaiskos, Ioannis
    Alexiou, Ioannis
    Pateras, Ioannis
    Konstantoudakis, Konstantinos
    Stamatakos, Michael
    ONCOLOGY, 2013, 84 (04) : 219 - 225
  • [22] Ki67 in breast cancer: prognostic and predictive potential
    Yerushalmi, Rinat
    Woods, Ryan
    Ravdin, Peter M.
    Hayes, Malcolm M.
    Gelmon, Karen A.
    LANCET ONCOLOGY, 2010, 11 (02): : 174 - 183
  • [23] Improvement of Ki67 Staining in Breast Cancer (BC)
    Muftah, A. A.
    Aleskandarany, M.
    Al-Kaabi, M. M.
    Jerjees, D. A.
    Abduljabbar, R. F.
    Alsubhi, N. H.
    Ellis, I. O.
    Rakha, E. A.
    Green, A. R.
    JOURNAL OF PATHOLOGY, 2015, 237 : S30 - S30
  • [24] A novel model for Ki67 assessment in breast cancer
    Quinci Romero
    Pär-Ola Bendahl
    Mårten Fernö
    Dorthe Grabau
    Signe Borgquist
    Diagnostic Pathology, 9
  • [25] Ki67 Assessment in Breast Cancer: Are We There Yet?
    Reis-Filho, Jorge S.
    Davidson, Nancy E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 797 - 798
  • [26] KI67 Expression in Primary Male Breast Cancer
    Erices-Leclercq, Melanie
    Rudlowski, Christian
    Baldus, Stephan
    Foerster, Frank
    Schroeder, Lars
    Stiller, Franziska
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 27 - 28
  • [27] A novel model for Ki67 assessment in breast cancer
    Romero, Quinci
    Bendahl, Par-Ola
    Ferno, Marten
    Grabau, Dorthe
    Borgquist, Signe
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [28] Ki67 is a promising molecular target in the diagnosis of cancer
    Li, Lian Tao
    Jiang, Guan
    Chen, Qian
    Zheng, Jun Nian
    MOLECULAR MEDICINE REPORTS, 2015, 11 (03) : 1566 - 1572
  • [29] Interlaboratory variability of Ki67 staining in breast cancer
    Focke, Cornelia M.
    Buerger, Horst
    van Diest, Paul J.
    Finsterbusch, Kai
    Glaeser, Doreen
    Korsching, Eberhard
    Decker, Thomas
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 219 - 227
  • [30] Chromogranin A Expression and Ki67 Index in Residual Rectal Cancer Treated with Preoperative Therapy
    Vecchio, F. M.
    Arena, V.
    Barba, M. C.
    Castri, F.
    Doglietto, G. B.
    Coco, C.
    Crucitti, A.
    Ricci, R.
    Corbosiero, A.
    Valerio, L.
    Valentini, V.
    LABORATORY INVESTIGATION, 2011, 91 : 171A - 172A
12345